Stay updated with breaking news from Acelyrin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Piper Sandler initiated coverage on shares of Acelyrin (NASDAQ:SLRN – Get Rating) in a research note issued to investors on Tuesday morning, The Fly reports. The firm issued an overweight rating and a $68.00 target price on the stock. Acelyrin Price Performance Shares of SLRN opened at $17.85 on Tuesday. Acelyrin has a 1-year low […]
Investment analysts at Jefferies Financial Group began coverage on shares of Acelyrin (NASDAQ:SLRN – Get Rating) in a research report issued on Tuesday, The Fly reports. The brokerage set a “buy” rating and a $31.00 price target on the stock. Jefferies Financial Group’s price target would suggest a potential upside of 71.27% from the stock’s […]
Acelyrin, Inc. (NASDAQ:SLRN – Get Rating) rose 7% during trading on Thursday . The stock traded as high as $22.72 and last traded at $22.51. Approximately 233,153 shares traded hands during mid-day trading, a decline of 80% from the average daily volume of 1,164,579 shares. The stock had previously closed at $21.03. Acelyrin Price Performance […]
Shares of Acelyrin, Inc. (NASDAQ:SLRN – Get Rating) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $20.00 and last traded at $20.03, with a volume of 12375 shares trading hands. The stock had previously closed at $20.72. Acelyrin Price Performance Insider Transactions at Acelyrin In related […]
Acelyrin, Inc. (NASDAQ:SLRN – Get Rating) major shareholder Biopartners Fund Ii Westlake purchased 1,250,000 shares of the company’s stock in a transaction on Tuesday, May 9th. The stock was acquired at an average price of $18.00 per share, for a total transaction of $22,500,000.00. Following the completion of the transaction, the insider now owns 9,790,729 […]